StockData
Prestige Consumer Healthcare Inc. logo

Prestige Consumer Healthcare Inc. (PBH) stock

PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$49.63+0.03 (+0.06%)

Close on Nov 20, 2026Market cap $2.35BP/E 13.9Yield –

Prestige Consumer Healthcare revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Prestige Consumer Healthcare's revenue for the twelve months ending Jun 30, 2026 was $1.10B, down 1.4% year over year. For fiscal 2026 it was $1.09B, down 4.3% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $1.14B in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.09B-4.3%
FY2025Mar 31, 2025$1.14B+1.1%
FY2024Mar 31, 2024$1.13B-0.2%
FY2023Mar 31, 2023$1.13B+3.8%
FY2022Mar 31, 2022$1.09B+15.2%
FY2021Mar 31, 2021$943.37M-2.0%
FY2020Mar 31, 2020$963.01M-1.3%
FY2019Mar 31, 2019$975.78M-6.3%
FY2018Mar 31, 2018$1.04B+18.0%
FY2017Mar 31, 2017$882.06M+9.4%
FY2016Mar 31, 2016$806.25M+12.8%
FY2015Mar 31, 2015$714.62M+19.6%
FY2014Mar 31, 2014$597.38M-3.2%
FY2013Mar 31, 2013$616.92M+39.9%
FY2012Mar 31, 2012$441.09M+31.1%
FY2011Mar 31, 2011$336.51M+15.0%
FY2010Mar 31, 2010$292.60M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$265.71M+6.5%
Q4 FY2026CQ1 2026Mar 31, 2026$281.62M-5.0%
Q3 FY2026CQ4 2025Dec 31, 2025$283.44M-2.4%
Q2 FY2026CQ3 2025Sep 30, 2025$274.11M-3.4%
Q1 FY2026CQ2 2025Jun 30, 2025$249.53M-6.6%
Q4 FY2025CQ1 2025Mar 31, 2025$296.52M+7.0%
Q3 FY2025CQ4 2024Dec 31, 2024$290.32M+2.7%
Q2 FY2025CQ3 2024Sep 30, 2024$283.79M-0.9%
Q1 FY2025CQ2 2024Jun 30, 2024$267.14M-4.4%
Q4 FY2024CQ1 2024Mar 31, 2024$276.99M-3.1%
Q3 FY2024CQ4 2023Dec 31, 2023$282.74M+2.6%
Q2 FY2024CQ3 2023Sep 30, 2023$286.32M-1.0%
Q1 FY2024CQ2 2023Jun 30, 2023$279.31M+0.8%
Q4 FY2023CQ1 2023Mar 31, 2023$285.87M+7.1%
Q3 FY2023CQ4 2022Dec 31, 2022$275.52M+0.4%
Q2 FY2023CQ3 2022Sep 30, 2022$289.27M+4.7%
Q1 FY2023CQ2 2022Jun 30, 2022$277.06M+2.9%
Q4 FY2022CQ1 2022Mar 31, 2022$266.94M+12.3%
Q3 FY2022CQ4 2021Dec 31, 2021$274.47M+14.9%
Q2 FY2022CQ3 2021Sep 30, 2021$276.23M+16.3%
Q1 FY2022CQ2 2021Jun 30, 2021$269.18M+17.3%
Q4 FY2021CQ1 2021Mar 31, 2021$237.76M-5.4%
Q3 FY2021CQ4 2020Dec 31, 2020$238.79M-1.1%
Q2 FY2021CQ3 2020Sep 30, 2020$237.42M-0.3%
Q1 FY2021CQ2 2020Jun 30, 2020$229.39M-1.2%
Q4 FY2020CQ1 2020Mar 31, 2020$251.24M+4.2%
Q3 FY2020CQ4 2019Dec 31, 2019$241.55M+0.1%
Q2 FY2020CQ3 2019Sep 30, 2019$238.07M-0.5%
Q1 FY2020CQ2 2019Jun 30, 2019$232.15M-8.6%
Q4 FY2019CQ1 2019Mar 31, 2019$241.03M-5.8%
Q3 FY2019CQ4 2018Dec 31, 2018$241.41M-10.8%
Q2 FY2019CQ3 2018Sep 30, 2018$239.36M-7.2%
Q1 FY2019CQ2 2018Jun 30, 2018$253.98M-1.0%
Q4 FY2018CQ1 2018Mar 31, 2018$255.97M+6.4%
Q3 FY2018CQ4 2017Dec 31, 2017$270.62M+24.8%
Q2 FY2018CQ3 2017Sep 30, 2017$258.03M+20.0%
Q1 FY2018CQ2 2017Jun 30, 2017$256.57M–
Q4 FY2017CQ1 2017Mar 31, 2017$240.67M–
Q3 FY2017CQ4 2016Dec 31, 2016$216.76M–
Q2 FY2017CQ3 2016Sep 30, 2016$215.05M–

More Prestige Consumer Healthcare figures

See a number that looks wrong?